PLASTIPHARM: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PLASTIPHARM
Largest movements
- Receivables within one year -€43,764
down €43,764 (-6.6%), from €662,320 to €618,556
of which Trade receivables: -€34,621
- Other debts +€1.4m
up €1.4m (+564.0%), from €239,552 to €1.6m
- Debts after one year -€1.1m
no longer reported in 2025 (was €1.1m)
- Accrued charges and deferred income -€157,825
down €157,825 (-82.7%), from €190,834 to €33,009
- Profit (loss) carried forward -€66,779
down €66,779 (-362.9%), from -€18,403 to -€85,182
- Write-downs -€105,186
new in 2025: -€105,186
- Financial charges +€61,631
up €61,631 (+145.8%), from €42,258 to €103,889
of which Financial charges: +€30,931
- Financial income +€33,454
up €33,454 (+334.5%), from €10,002 to €43,455
of which Non-recurring financial income: +€35,985
- Gross operating margin -€532
down €532 (-11.3%), from -€4,715 to -€5,248
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,599,380 | €1,583,034 | -€16,346 | -1.0% |
| Fixed assets | 21/28 | €859,646 | €877,000 | +€17,354 | +2.0% |
| Tangible fixed assets | 22/27 | €383,887 | €385,614 | +€1,727 | +0.4% |
| Other tangible fixed assets | 26 | €383,887 | €385,614 | +€1,727 | +0.4% |
| Financial fixed assets | 28 | €475,759 | €491,386 | +€15,627 | +3.3% |
| Current assets | 29/58 | €739,733 | €706,034 | -€33,699 | -4.6% |
| Amounts receivable within one year | 40/41 | €662,320 | €618,556 | -€43,764 | -6.6% |
| Trade receivables | 40 | €41,223 | €6,602 | -€34,621 | -84.0% |
| Other amounts receivable | 41 | €621,097 | €611,954 | -€9,143 | -1.5% |
| Cash at bank and in hand | 54/58 | €4,413 | €7,008 | +€2,594 | +58.8% |
| Deferred charges and accrued income | 490/1 | €73,000 | €80,470 | +€7,470 | +10.2% |
| Total equity and liabilities | 10/49 | €1,599,380 | €1,583,034 | -€16,346 | -1.0% |
| Equity | 10/15 | €12,305 | -€54,474 | -€66,779 | |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €12,107 | €12,107 | = | 0.0% |
| Non-distributable reserves | 130/1 | €12,107 | €12,107 | = | 0.0% |
| Reserves not available under the articles | 1311 | €12,107 | €12,107 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€18,403 | -€85,182 | -€66,779 | -362.9% |
| Amounts payable | 17/49 | €1,587,075 | €1,637,508 | +€50,433 | +3.2% |
| Amounts payable after more than one year | 17 | €1,146,335 | - | -€1.1m | |
| Other amounts payable | 178/9 | €1,146,335 | - | -€1.1m | |
| Amounts payable within one year | 42/48 | €249,906 | €1,604,500 | +€1.4m | +542.0% |
| Trade debts | 44 | €10,354 | €13,872 | +€3,517 | +34.0% |
| Suppliers | 440/4 | €10,354 | €13,872 | +€3,517 | +34.0% |
| Other amounts payable | 47/48 | €239,552 | €1,590,628 | +€1.4m | +564.0% |
| Accrued charges and deferred income | 492/3 | €190,834 | €33,009 | -€157,825 | -82.7% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | - | -€105,186 | -€105,186 | |
| Other operating charges | 640/8 | €1,104 | €1,098 | -€6 | -0.5% |
| Non-recurring operating charges | 66A | - | €105,186 | +€105,186 | |
| Gross operating margin | 9900 | -€4,715 | -€5,248 | -€532 | -11.3% |
| Operating profit (loss) | 9901 | -€5,819 | -€6,346 | -€526 | -9.0% |
| Financial income | 75/76B | €10,002 | €43,455 | +€33,454 | +334.5% |
| Recurring financial income | 75 | €10,002 | €7,470 | -€2,532 | -25.3% |
| Non-recurring financial income | 76B | - | €35,985 | +€35,985 | |
| Financial charges | 65/66B | €42,258 | €103,889 | +€61,631 | +145.8% |
| Recurring financial charges | 65 | €42,258 | €73,189 | +€30,931 | +73.2% |
| Non-recurring financial charges | 66B | - | €30,700 | +€30,700 | |
| Profit (loss) for the period before taxes | 9903 | -€38,075 | -€66,779 | -€28,704 | -75.4% |
| Profit (loss) for the period | 9904 | -€38,075 | -€66,779 | -€28,704 | -75.4% |
| Profit (loss) for the period to be appropriated | 9905 | -€38,075 | -€66,779 | -€28,704 | -75.4% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.